These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 11112383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 14; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

  • 6. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1990 Apr 12; 322(15):1037-45. PubMed ID: 1690857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
    Vasavda N, Badiger S, Rees D, Height S, Howard J, Thein SL.
    Br J Haematol; 2008 Nov 12; 143(4):589-92. PubMed ID: 18764867
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH, Al-Dabbous IA.
    Saudi Med J; 2002 Mar 12; 23(3):277-81. PubMed ID: 11938415
    [Abstract] [Full Text] [Related]

  • 10. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK, McCarthy WF, Guo N, Brugnara C, Kling G, Bauserman RL, Waclawiw MA.
    Hemoglobin; 2010 Mar 12; 34(5):424-9. PubMed ID: 20854115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar 12; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 14. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A, Gumruk F, Gurgey A.
    Pediatr Hematol Oncol; 2003 Sep 12; 20(6):429-34. PubMed ID: 14631615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P, Pecoraro A, Calvaruso G, Steinberg MH, Iannello S, Maggio A.
    Am J Hematol; 2013 Nov 12; 88(11):E261-4. PubMed ID: 23828131
    [Abstract] [Full Text] [Related]

  • 19. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 12; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 20. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R, Hsieh MM, Zhao X, Calvaruso G, Rigano P, Renda D, Tisdale JF, Maggio A.
    Int J Mol Sci; 2018 Feb 28; 19(3):. PubMed ID: 29495591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.